A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease

Neurology

Volumn 47, Issue 1, 1996, Pages 256-259

  Ramachandran, G ^a,c,d,e   Marder, K ^a,c   Tang, M ^a,b   Schofield, P W ^a,c   Chun, M R ^a,c   Devanand, D P ^c   Stern, Y ^a,c   Mayeux, R ^a,b,c  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c State University of New York ^*  (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e Long Isl Alzheimer's Dis Assit C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E3;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; DEPRESSION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NERVE CELL NETWORK; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PSYCHOSIS;

EID: 0030015853     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.1.256     Document Type: Article

References (10)

1. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437.
2. Lopez-Alberola R, Gilchrist D, Barker WW, St. George-Hyslop P, Duara R. Analysis of phenotype in Alzheimer's disease (AD) associated with apolipoprotein E (APOE) alleles [abstract]. Neurology 1994;44(suppl. 2):A207.
3. Zubenko GS, Moossy J, Martinez HJ, et al. Neuropathological and neurochemical correlates of psychosis in primary dementia. Arch Neurol 1991;48:619-624.
4. Zubenko GS, Moossy J. Major depression in primary dementia. Clinical and neuropathologic correlates. Arch Neurol 1988;45:1182-1186.
5. Zubenko GS, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990;47: 209-214.
6. Gurland B, Wilder D, Cross P, et al. Relative rates of dementia by multiple case definition, over two previous periods, in three cultural groups. Am J Geriatr Psychiatry 1995;3:6-20.
7. Katzman R, Brown T, Fluid P, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983;140:734-738.
8. Morris JC, McKeel DWW, Storandt M, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991;41: 469-478.
9. Vida S, Des Rosiers P, Carrier L, Gauthier S. Depression in Alzheimer's disease: receiver operating characteristic analysis of the Cornell scale for depression in dementia and the Hamilton depression scale. J Geriatr Psychiatry Neurol 1994;7: 159-162.
10. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-9653.